Kira Rubtsova
Eli Lilly and Company
Dr. Kira Rubtsova is a senior research scientist in Immunology Discovery, at Eli Lilly and Company, San Diego. She earned her PhD at University of Colorado in laboratory of Dr. John Kappler studying TCR-MHC interactions. She did her post doc training at National Jewish Health Center in laboratory of Dr. Pippa Marrack, where she studied B cells in the context of autoimmunity working on novel subset of B cells – Age-Associated B cells, ABCs, and their role in the development of autoimmunity. At Eli Lilly Dr. Rubtsova is a project leader of large, cross-functional team developing large molecule therapeutics for treatment of autoimmune diseases. | Kira Rubtsova, PhD. |. Senior Research Scientist, Discovery, Immunology, Eli Lilly and Company
Appearances
DateMarch 25, 2022B cells contribute to multiple aspects of autoimmune disorders through autoantibody production, antigen presentation, cytokine secretion, and formation of tertiary lymphoid structures. B cell targeting therapies have been developed and approved for treatment of autoimmune diseases…Speaker
Eli Lilly and CompanyFreeStandard Price
